Research News and Research

RSS

LaserBand signs an agreement for healthcare wristbands and labels with MedAssets Supply Chain Systems

LaserBand, the leading provider of patient identification wristbands and related products, recently signed an agreement for healthcare wristbands and labels with MedAssets Supply Chain Systems, one of the nation’s largest group purchasing organizations (GPO).

5 Nov 2009

Home Diagnostics announces financial results for third quarter 2009; reports decreased gross margin

Home Diagnostics, Inc. (Nasdaq:HDIX), a leading manufacturer and marketer of diabetes testing supplies, today announced financial results for the third quarter ended September 30, 2009.

5 Nov 2009

I-Flow reports financial results for the third quarter of 2009

I-FLOW CORPORATION announced today that total revenue for the third quarter ended September 30, 2009 increased 14% to $36.7 million compared to total revenue of $32.2 million for the third quarter of 2008.

5 Nov 2009

Third-quarter financial results for the year 2009 announced by Biovail

Biovail Corporation today announced financial results for the three-month and nine-month periods ended September 30, 2009. To the extent that this news release contains forward-looking statements, investors are cautioned that these statements are based on the Company’s current views, and actual outcomes are not certain.

5 Nov 2009

ArQule reports financial results for the fiscal quarter and nine months ended September 30, 2009

ArQule, Inc. today reported its results of operations for the fiscal quarter and nine months ended September 30, 2009.

5 Nov 2009

Idera Pharmaceuticals announces financial results for the third quarter of 2009

Idera Pharmaceuticals, Inc. today reported financial results for the third quarter and nine months ended September 30, 2009.

5 Nov 2009

Inspire Pharmaceuticals reports net loss of $8.5 million for the third quarter ended September 30, 2009

Inspire Pharmaceuticals, Inc. announced today financial results for the third quarter ended September 30, 2009, reporting a net loss of $8.5 million or ($0.12) per common share.

5 Nov 2009

FDA approves the New Drug Application for Pennsaid Topical Solution

Covidien, a leading global provider of healthcare products, and Nuvo Research Inc., a Canadian drug development company, today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for Pennsaid(R) Topical Solution (diclofenac sodium topical solution) 1.5% w/w.

5 Nov 2009

Second-quarter fiscal 2010 results announced by Repligen

Repligen Corporation today reported results for the second quarter of fiscal year 2010, ended September 30, 2009. Total revenue for the quarter was $5,421,000 compared to total revenue of $5,090,000 for the second quarter of fiscal year 2009 ended September 30, 2008.

5 Nov 2009

Compugen signs research and license agreement with a leading diagnostic company

Compugen Ltd. announced today that it has signed a research and license agreement with a leading diagnostic company covering CGEN-226, a novel biomarker candidate for early detection of preeclampsia.

5 Nov 2009

Middlebrook Pharmaceuticals announces financial and operational results for third quarter 2009

MiddleBrook Pharmaceuticals, Inc. today announced its financial and operational results for the quarter ended Sept. 30, 2009.

5 Nov 2009

Alnylam Pharmaceuticals presents new data related to its overall delivery research efforts

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it presented new data related to its overall delivery research efforts including the rational design of Mimetic Lipoprotein Particles, or MLPs, a novel technology for the systemic delivery of small interfering RNAs, or siRNAs, the molecules that mediate RNAi.

5 Nov 2009

Third quarter 2009 financial results announced by Aradigm

Aradigm Corporation (OTCBB:ARDM) (the “Company”) today announced financial results for the third quarter and nine months ended September 30, 2009 and recent highlights.

5 Nov 2009

Pennsaid Topical Solution approved by FDA

Covidien, a leading global provider of healthcare products, and Nuvo Research Inc. (TSX:NRI), a Canadian drug development company, today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application for Pennsaid® Topical Solution (diclofenac sodium topical solution) 1.5% w/w.

5 Nov 2009

Columbia Laboratories reports net revenues of $7.9 million for third quarter 2009

Columbia Laboratories, Inc. today reported financial results for the three- and nine-month periods ended September 30, 2009.

5 Nov 2009

Five life-saving tips to survive a hospital stay

With the numbers of H1N1 (Swine Flu) cases flooding emergency rooms all over the country, you'll want to do everything you can to prevent contracting H1N1 and being subjected to fatal medical errors and infectious diseases if you have to go into the hospital. Martine Ehrenclou, author of the multiple award winning book, Critical Conditions: The Essential Hospital Guide To Get Your Loved One Out Alive, offers five life-saving tips to stay safe and free of disease if you have to be in the hospital.

5 Nov 2009

STMicroelectronics and Mayo Clinic collaborate on a novel heart-monitoring platform

STMicroelectronics, one of the world's leading semiconductor companies, and Mayo Clinic, a premier health-care organization, are collaborating on a novel platform for remotely monitoring patients with chronic cardiovascular disease.

5 Nov 2009

Study finds oral dimercaptosuccinic acid effective in treating children with autism

Two studies published by the Southwest College of Naturopathic Medicine in the October issue of BMC Clinical Pharmacology investigated the use of oral dimercaptosuccinic acid (DMSA), a prescription medicine approved by the FDA for treating lead poisoning, and used off-label in these studies for treating heavy metal toxicity in children with autism.

5 Nov 2009

Prenatal DHA, a product developed for pregnant women to ensure adequate DHA, introduced

Nordic Naturals Professional Exclusive Division announces Prenatal DHA, a product developed especially for pregnant women to ensure adequate DHA, an important omega-3 essential fatty acid and a vital nutrient for the new mother and developing baby.

5 Nov 2009

Case Western Reserve images heart tissue through Avo produced OCT catheters

Nearly 4 million people nationwide suffer from cardiac arrhythmias each year, according to the 2006 U.S. Cardiac Rhythm Management Market report by Frost and Sullivan. About 2.5 million of these cases cannot be treated or controlled through medication alone. Since pharmacological therapies have limited effectiveness, radiofrequency (RF) catheter ablation has emerged as the prominent approach for treating a broad range of arrhythmias.

5 Nov 2009

Research News and Research

LaserBand signs an agreement for healthcare wristbands and labels with MedAssets Supply Chain Systems

Home Diagnostics announces financial results for third quarter 2009; reports decreased gross margin

I-Flow reports financial results for the third quarter of 2009

Third-quarter financial results for the year 2009 announced by Biovail

ArQule reports financial results for the fiscal quarter and nine months ended September 30, 2009

Idera Pharmaceuticals announces financial results for the third quarter of 2009

Inspire Pharmaceuticals reports net loss of $8.5 million for the third quarter ended September 30, 2009

FDA approves the New Drug Application for Pennsaid Topical Solution

Second-quarter fiscal 2010 results announced by Repligen

Compugen signs research and license agreement with a leading diagnostic company

Middlebrook Pharmaceuticals announces financial and operational results for third quarter 2009

Alnylam Pharmaceuticals presents new data related to its overall delivery research efforts

Third quarter 2009 financial results announced by Aradigm

Pennsaid Topical Solution approved by FDA

Columbia Laboratories reports net revenues of $7.9 million for third quarter 2009

Five life-saving tips to survive a hospital stay

STMicroelectronics and Mayo Clinic collaborate on a novel heart-monitoring platform

Study finds oral dimercaptosuccinic acid effective in treating children with autism

Prenatal DHA, a product developed for pregnant women to ensure adequate DHA, introduced

Case Western Reserve images heart tissue through Avo produced OCT catheters

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News